The historical rank and industry rank for BioXcel Therapeutics's Days Inventory or its related term are showing as below:
STU:BX2'
s Days Inventory Range Over the Past 10 Years
Min: 571.44 Med: 18401.07 Max: 36226.25
Current: 571.44
During the past 8 years, BioXcel Therapeutics's highest Days Inventory was 36226.25. The lowest was 571.44. And the median was 18401.07.
STU:BX2's Days Inventory is ranked worse than 83.38% of 650
companies
in the Biotechnology industry
Industry Median: 190.305
vs STU:BX2: 571.44
BioXcel Therapeutics's Days Inventory
declined
from Mar. 2023 (21,084.45) to Mar. 2024 (2,543.75).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioXcel Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2024 was 0.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioXcel Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2024 was 3.80.
BioXcel Therapeutics Days Inventory Historical Data
The historical data trend for BioXcel Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioXcel Therapeutics's Days Inventory
For the Biotechnology subindustry, BioXcel Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioXcel Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioXcel Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioXcel Therapeutics's Days Inventory falls into.
BioXcel Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioXcel Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioXcel Therapeutics (STU:BX2) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioXcel Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioXcel Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioXcel Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of BioXcel Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
BioXcel Therapeutics (STU:BX2) Business Description
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:BX2 has been successfully added to your 